Holding(s) in Company (7752B)

TIDMHIK

RNS Number : 7752B

Hikma Pharmaceuticals Plc

20 April 2012

Notification of Major Interests in Shares

LONDON, 20 April 2012 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals group, announces as follows:

 
 1   Identity of the issuer or the underlying   Hikma Pharmaceuticals PLC 
      issuer of existing shares to which the 
      voting rights are attached 
    -----------------------------------------  -------------------------- 
 
 
 2   Reason for the notification 
    -------------------------------------------------  ---- 
     An acquisition or disposal of voting               Yes 
      rights 
    -------------------------------------------------  ---- 
     An acquisition or disposal of financial            No 
      instruments which may result in the acquisition 
      of shares already issues to which voting 
      rights are attached 
    -------------------------------------------------  ---- 
     An event changing the breakdown of voting          No 
      rights 
    -------------------------------------------------  ---- 
     Other (please specify): Compliance with            No 
      the Transparency Directive 
    -------------------------------------------------  ---- 
 
 
 3   Full name of the person subject to the    Norges Bank 
      notification obligation 
    ----------------------------------------  -------------- 
 4   Full name of shareholders                 N/A 
    ----------------------------------------  -------------- 
 5   Date of the Transaction (and date on      19 April 2012 
      which the threshold crossed is reached 
      differently) 
    ----------------------------------------  -------------- 
 6   Date on which the issuer notified         20 April 2012 
    ----------------------------------------  -------------- 
 7   Threshold that is crossed                 4% 
    ----------------------------------------  -------------- 
 
 
 8   Notified details (ABC) 
    ----------------------- 
 
 
 A. Voting rights attached to shares 
----------------------------------------------------------------------------------------------------------- 
 Class type       Situation previous        Resulting situation after the triggering 
  of shares        to the triggering         transaction 
  (if possible     transaction 
  using the 
  ISIN code) 
---------------  ------------------------  ---------------------------------------------------------------- 
                  Number       Number       Number of shares       Number of voting       % of voting 
                   of shares    of voting                           rights                 rights 
                                rights 
---------------  -----------  -----------  ---------------------  ---------------------  ------------------ 
                                            Direct      Indirect   Direct      Indirect   Direct   Indirect 
---------------  -----------  -----------  ----------  ---------  ----------  ---------  -------  --------- 
 Ordinary 
  Shares (0.10 
  GBP) 
  GB00B0LCW083    7,965,535    7,965,535    7,579,731      0       7,579,731      0       3.87%       0% 
---------------  -----------  -----------  ----------  ---------  ----------  ---------  -------  --------- 
 
 
 B. Qualifying Financial instruments 
---------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration   Exercise/Conversion   Number of voting          % of voting rights 
  instrument          Date         Period/Date           rights that may 
                                                         be acquired if 
                                                         the instrument 
                                                         if exercised/converted 
------------------  -----------  --------------------  ------------------------  ------------------- 
 -                   -            -                     -                         - 
------------------  -----------  --------------------  ------------------------  ------------------- 
 
 
 C: Financial Instruments with similar economic effect to Qualifying 
  Financial Instruments 
------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------ 
 Type of       Exercise   Expiration   Exercise/Conversion   Number of voting     % of voting rights 
  financial     Price      Date         Period/Date           rights instrument 
  instrument                                                  refers to 
------------  ---------  -----------  --------------------  -------------------  --------------------- 
                                                                                  Nominal      Delta 
------------  ---------  -----------  --------------------  -------------------  -----------  -------- 
 -             -          -            -                     -                    -            - 
------------  ---------  -----------  --------------------  -------------------  -----------  -------- 
 
 
 Total A+B+C 
--------------------------------------------- 
 Number of Voting rights   % of voting rights 
------------------------  ------------------- 
 7,579,731                 3.87% 
------------------------  ------------------- 
 
 
 9   Chain of controlled undertakings through which the voting rights 
      and/or the financial instruments are effectively held, if applicable 
    ---------------------------------------------------------------------- 
      N/A 
    ---------------------------------------------------------------------- 
 
 
 Proxy Voting 
--------------------------------------------------------- 
 10   Name of the proxy holder                Norges Bank 
---  --------------------------------------  ------------ 
 11   Number of voting rights proxy holder    N/A 
       will cease to hold 
---  --------------------------------------  ------------ 
 12   Date on which proxy holder will cease   N/A 
       to hold voting rights 
---  --------------------------------------  ------------ 
 
 
 13   Additional Information      None 
---  --------------------------  ----------------------- 
 14   Contact name:               Jeanette Ronne, Norges 
                                   Bank 
---  --------------------------  ----------------------- 
 15   Contact telephone number:   +47 24 07 33 30 
---  --------------------------  -----------------------

- ENDS -

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non--branded generic and in--licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based principally in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2011, Hikma achieved revenue of $918.0 million and profit attributable to shareholders of $80.1 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLURSARUKASUAR

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024